Protective effect of crocin in ulcerative colitis rats and its related mechanism

doi:10.3969/j.issn.2095-4344.2817

Abstract

Abstract:

BACKGROUND: Crocin has anti-inflammatory and anti-oxidative stress effects. The therapeutic effects of crocin on ulcerative colitis and related mechanisms are still unclear.

OBJECTIVE: To explore the protective effect of crocin in ulcerative colitis rats and its related mechanism.

METHODS: Thirty Sprague-Dawley rats were randomly divided into five groups: normal group, model group, low-dose crocin group, high-dose crocin group, and positive control group. Experimental rat model of ulcerative colitis was induced by dextran sodium sulfate. Starting on the first day of modeling, rats were routinely fed in the normal group, were given sulfasalazine by gavage in the positive drug group, and were gavaged with 0.05 and 0.1 g/kg crocin in the low- and high-dose crocin groups, respectively.

RESULTS AND CONCLUSION: One week after intervention, the crocin-treated rats had significantly decreased scores on colon tissue injury and Crohn’s disease activity index (P < 0.05). Compared with the model group, crocin groups had a decrease in the content of malondialdehyde and activity of myeloperoxidase (P < 0.05), and an increase in the activity of superoxide dismutase in the colon tissue (P < 0.05). Shown by immunohistochemical staining, compared with the model group, treatment with crocin significantly reduced immune responses of tumor necrosis factor α and interleukin 23 proteins after 1 week of intervention (P < 0.05). Compared with the model group, treatment with crocin downregulated the expression levels of total protein Bax, Caspase-3, Toll-like receptor 4 and MyD88 (P < 0.05), and upregulated the expression of Bcl-2 in the intestinal tissue of rats (P < 0.05). These results indicate that crocin has a certain therapeutic effect in ulcerative colitis rats and its mechanism may be related to down-regulation of the Toll-like receptor 4/MyD88 signaling pathway and inhibition of oxidative stress, inflammation and apoptosis in the colon.

Key words: crocin, dextran sulphate sodium, ulcerative colitis, animal model, Toll-like receptor 4/MyD88, tumor necrosis factor-α, interleukin23, oxidative stress, apoptosis, rat

CLC Number:

Yang Minjie, Liu Wei, Tu Hongfei, Li Li, Fei Sujuan. Protective effect of crocin in ulcerative colitis rats and its related mechanism[J]. Chinese Journal of Tissue Engineering Research, 2020, 24(29): 4673-4679.

Figures/Tables 9

References

[1] BEVIVINO G, MONTELEONE G. Advances in understanding the role of cytokines in inflammatory boweldisease. Expert Rev Gastroenterol Hepatol. 2018;12(9):907-915.

[2] CASTRO-DOPICO T, DENNISON TW, FERDINAND JR, et al. Anti-commensal IgG drives intestinal inflammation and type 17 immunity in ulcerative colitis. Immunity. 2019;50(4): 1099-1114.

[3] FRIEDRICH M, POHIN M, POWRIE F. Cytokine networks in the pathophysiology of inflammatory bowel disease. Immunity. 2019;50(4):992-1006.

[4] NI Y, LIU M, YU H, et al. Desmethylbellidifolin from gentianella acuta ameliorate TNBS-Induced ulcerative colitis through antispasmodic effect and anti-inflammation. Front Pharmacol. 2019;10(9):1-12.

[5] NING L, LOU X, ZHANG F, et al. Nuclear receptors in the pathogenesis and management of inflammatory bowel disease. Mediators Inflamm. 2019;2019(1):1-13.

[6] FAGUNDES DJ, CARRARA FL, TEIXEIRA WA, et al. The role of the exogenous supply of adenosine triphosphate in the expression of Bax and Bcl2L1 genes in intestinal ischemia and reperfusion in rats 1. Acta Cir Bras. 2018;33(10):889-895.

[7] HASAN A, AKHTER N, AL-ROUB A, et al. TNF-α in combination with palmitate enhances IL-8 production via The MyD88- Independent TLR4 signaling pathway: potential relevance to metabolic inflammation. Int J Mol Sci. 2019;20(17): E4112.

[8] LI Z, WANG G, FENG D, et al. Targeting the miR-665-3p-ATG4B-autophagy axis relieves inflammation and apoptosis in intestinal ischemia/reperfusion. Cell Death Dis. 2018;9(5):483.

[9] WATANABE T, HIGUCHI K, KOBATA A, et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut. 2007;57(2):181-187.

[10] LARUSSA T, IMENEO M, LUZZA F. Olive tree biophenols in inflammatory bowel disease: when bitter is better. Int J Mol Sci. 2019;20(6):1-13.

[11] KIM WS, SONG HY, MUSHTAQ S, et al. Therapeutic potential of gamma-irradiated resveratrol in ulcerative colitis via the anti-inflammatory activity and differentiation of tolerogenic dendritic cells. Cell Physiol Biochem. 2019;52(5):1117-1138.

[12] GEDIK S, ERDEMLI ME, GUL M, et al. Investigation of the protective effects of crocin on acrylamide induced small and large intestine damage in rats. Biotech Histochem. 2018; 93(4):267-276.

[13] CAO L, XU H, WANG G, et al. Extracellular vesicles derived from bone marrow mesenchymal stem cells attenuate dextran sodium sulfate-induced ulcerative colitis by promoting M2 macrophage polarization. Int Immunopharmacol. 2019;72(4): 264-274.

[14] CHASSAING B, AITKEN JD, MALLESHAPPA M, et al. Dextran sulfate sodium (DSS)-induced colitis in mice. Curr Protoc Immunol. 2014;104(15):11-14.

[15] GAO W, WANG C, YU L, et al. Chlorogenic Acid attenuates dextran sodium sulfate-induced ulcerative colitis in mice through MAPK/ERK/JNK pathway. Biomed Res Int. 2019; 2019(18):1-13.

[16] KORANI S, KORANI M, SATHYAPALAN T, et al. Therapeutic effects of Crocin in autoimmune diseases: a review. BioFactors. 2019;45(6):835-843.

[17] BING X, XUELEI L, WANWEI D, et al. EGCG Maintains Th1/Th2 balance and mitigates ulcerative colitis induced by dextran sulfate sodium through TLR4/MyD88/NF-kappab signaling pathway in rats. Can J Gastroenterol Hepatol. 2017; 2017(11):1-9.

[18] JEON YD, BANG KS, SHIN MK, et al. Regulatory effects of glycyrrhizae radix extract on DSS-induced ulcerative colitis. BMC Complement Altern Med. 2016;16(1):459.

[19] CALABRESI MFF, TANIMOTO A, PRÓSPERO AG, et al. Changes in colonic contractility in response to inflammatory bowel disease: long-term assessment in a model of TNBS-induced inflammation in rats. Life Sci. 2019;236(9):1-8.

[20] ZHENG JD, HE Y, YU HY, et al. Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation. World J Gastroenterol. 2019;25(15):1865-1878.

[21] NEURATH MF. IL-23 in inflammatory bowel diseases and colon cancer. Cytokine Growth Factor Rev. 2019;45(12):1-8.

[22] WONG U, CROSS RK. Expert opinion on interleukin-12/23 and interleukin-23 antagonists as potential therapeutic options for the treatment of inflammatory bowel disease. Expert Opin Investig Drugs. 2019;28(5):473-479.

[23] TOTH S, JONECOVA Z, MARETTA M, et al. The effect of Betanin parenteral pretreatment on Jejunal and pulmonary tissue histological architecture and inflammatory response after Jejunal ischemia-reperfusion injury. Exp Mol Pathol. 2019;110(10):1-9.

[24] POPE MR, HOFFMAN SM, Tomlinson S, et al. Complement regulates TLR4-mediated inflammatory responses during intestinal ischemia reperfusion. Mol Immunol. 2010;48(1-3): 356-364.

[25] KAWAI T, AKIRA S. The roles of TLRs, RLRs and NLRs in pathogen recognition. Int Immunol. 2009;21(4):317-337.

[26] BARBALHO SM, BOSSO H, SALZEDAS-PESCININI LM, et al. Green tea: a possibility in the therapeutic approach of inflammatory bowel diseases? Complementary Ther Med. 2019;43(1):148-153.

[27] LI B, YAO X, LUO Y, et al. Inhibition of Autophagy Attenuated Intestinal Injury After Intestinal I/R via mTOR Signaling. J Surg Res. 2019;243(3):363-370.

[28] YAN Y, LV X, MA J, et al. Simvastatin alleviates intestinal ischemia/reperfusion injury by modulating Omi/HtrA2 signaling pathways. Transplant Proc. 2019;51(8):2798-2807.

[29] FAN W, FEI G, LI X, et al. Sera with anti-enteric neuronal antibodies from patients with irritable bowel syndrome promote apoptosis in myenteric neuronsof guinea pigs and human SH-Sy5Y cells. Neurogastroenterol Motil. 2018;30(12): 1-15.

[30] ZU G, ZHOU T, CHE N, et al. Salvianolic Acid A Protects Against OxidativeStress and Apoptosis Induced by Intestinal Ischemia-Reperfusion Injury Through Activation of Nrf2/HO-1 Pathways. Cell Physiol Biochem. 2018;49(6):2320-2332.